HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Hemalatha Vasireddy, MD

Board Certifications: Hematology, Internal Medicine and Medical Oncology

Specializations: Hematology and Medical Oncology

Languages: English and Telugu

Locations: Belleville, NJ, Montclair, NJ and Roselle, NJ

Dr. Vasireddy has been practicing medicine in New Jersey for more than 15 years. She completed comprehensive training in hematology and medical oncology with an emphasis on both inpatient and outpatient medical management. She also instructs internal medicine residents in hematology/oncology at the University of Medicine and Dentistry of New Jersey/Mountainside Hospital. She is a member of the Oncology Care Committee and co-chairman of the Transfusion Committee at Clara Maass Medical Center in Belleville.

Education

Medical Education

  • Bachelor of Medicine, Bachelor of Surgery, Guntur Medical College, University of Health Sciences, Guntar, India

RESIDENCY

  • New York Methodist Hospital affiliated with NY Hospital Cornell Medical Center

FELLOWSHIPS

  • Hematology/Oncology, New York Methodist Hospital affiliated with NY Hospital Cornell Medical Center

OBSERVERSHIP

  • Jersey Shore Medical Center

Awards and honors

PROFESSIONAL MEMBERSHIPS

  • American Society of Clinical Oncology

  • American College of Physicians

  • Oncology Society of New Jersey

  • Cancer Committee at Mountainside Hospital in Montclair

HOSPITAL AFFILIATIONS

Staff physician at Clara Maass Medical Center in Belleville, Mountainside Hospital in Montclair, Cooperman Barnabas Medical Center in Livingston

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.